Healthy high growth potential

Results

1517

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1517 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł224.701.5%-16.9%zł22.4bzł234.5643.526.9%0.4%Media
AGP
€7.022.9%-15.3%€128.0m€8.5725.837.8%n/aCapital Goods
COXG
€12.00-4.4%28.8%€1.0b€15.3514.824.7%n/aUtilities
AXSM
US$252.162.4%145.1%US$13.0bUS$276.4718.357.4%n/aPharmaceuticals & Biotech
MDGL
US$499.866.1%76.8%US$11.6bUS$678.7110.259.2%n/aPharmaceuticals & Biotech
FWRY
ج.م18.914.5%71.0%ج.م64.4bج.م20.3325.627.2%n/aDiversified Financials
456A
JP¥1,679.006.7%n/aJP¥149.6bn/a47.522.0%n/aRetail
LITE
US$869.982.0%883.5%US$68.1bUS$1,111.29154.279.1%n/aTech
NVDA
US$204.65-0.1%40.7%US$5.0tUS$298.9331.121.8%0.5%Semiconductors
RHM
€1,170.20-2.3%-32.8%€54.5b€1,889.3851.930.8%1.0%Capital Goods
CRDO
US$249.334.9%191.3%US$44.6bUS$256.3098.427.5%n/aSemiconductors
CORT
US$81.754.6%14.8%US$9.0bUS$88.00188.048.9%n/aPharmaceuticals & Biotech
MOD
US$283.8810.0%195.4%US$15.1bUS$340.86123.449.2%n/aCapital Goods
4417
JP¥3,265.007.8%2.7%JP¥48.7bJP¥4,500.0033.024.1%1.0%Software
9218
JP¥702.004.5%6.0%JP¥7.3bn/a31.028.9%1.4%Healthcare
7769
NT$6,980.00-1.1%449.6%NT$1.3tNT$9,158.4387.143.3%0.9%Semiconductors
2315
HK$40.946.3%89.5%HK$38.8bHK$62.0254.340.4%n/aPharmaceuticals & Biotech
6990
HK$415.805.4%29.4%HK$94.1bHK$547.6440.644.8%n/aPharmaceuticals & Biotech
2171
HK$15.75-1.3%-34.8%HK$9.3bHK$21.2264.382.1%n/aPharmaceuticals & Biotech
325
HK$47.30-12.1%-69.3%HK$12.0bHK$81.0016.022.7%n/aConsumer Durables
1729
HK$19.0519.1%174.5%HK$44.9bHK$25.0054.233.6%0.3%Capital Goods
NORTHERN
RM 0.632.4%5.0%RM 253.2mRM 1.0016.339.5%n/aCapital Goods
1357
HK$4.38-6.4%-42.8%HK$21.3bHK$9.3723.531.5%2.3%Media
3881
HK$23.8430.3%n/aHK$10.2bn/a10.2107.6%n/aCapital Goods
Page 1 of 43